Free Trial

Sana Biotechnology (SANA) News Today

Sana Biotechnology logo
$3.16 -0.09 (-2.77%)
As of 01/17/2025 04:00 PM Eastern
Dedicated scientist group working on advance biotechnology computer software to study or analyze DNA data after making scientific breakthrough from chemical experiment on medical laboratory. Neoteric
There May Still Be Time to Get in on These 3 Trending Biotechs (SANA)
Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025.
Sana Biotechnology, Inc. stock logo
Sana Biotechnology (NASDAQ:SANA) Shares Gap Down - What's Next?
Sana Biotechnology (NASDAQ:SANA) Shares Gap Down - Time to Sell?
Sana Biotechnology, Inc. stock logo
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 5.5% - What's Next?
Sana Biotechnology (NASDAQ:SANA) Trading Down 5.5% - Here's Why
Sana Biotechnology, Inc. stock logo
Sana Biotechnology (NASDAQ:SANA) Trading Down 5.5% - What's Next?
Sana Biotechnology (NASDAQ:SANA) Shares Down 5.5% - What's Next?
Sana Biotechnology, Inc. stock logo
Sana Biotechnology (NASDAQ:SANA) Trading Up 5.7% - Still a Buy?
Sana Biotechnology (NASDAQ:SANA) Shares Up 5.7% - Here's What Happened
Sana Biotechnology, Inc. stock logo
Barclays PLC Increases Stock Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA)
Barclays PLC raised its stake in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 126.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 318,910 shares of the company's stock after buying an additional 178,17
Sana Biotechnology price target raised to $12 from $9 at Morgan Stanley
Sana Biotechnology, Inc. stock logo
Insider Selling: Sana Biotechnology, Inc. (NASDAQ:SANA) Insider Sells 290,912 Shares of Stock
Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) insider Fmr Llc sold 290,912 shares of Sana Biotechnology stock in a transaction dated Wednesday, January 8th. The shares were sold at an average price of $6.49, for a total value of $1,888,018.88. Following the sale, the insider now owns 4,541,511 shares of the company's stock, valued at approximately $29,474,406.39. This represents a 6.02 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Sana Biotechnology, Inc. stock logo
Sana Biotechnology (NASDAQ:SANA) Shares Gap Up - Time to Buy?
Sana Biotechnology (NASDAQ:SANA) Shares Gap Up - What's Next?
Sana Biotechnology (NASDAQ:SANA) Upgraded to Buy at TD Cowen
Sana Biotechnology, Inc. stock logo
Sana Biotechnology (NASDAQ:SANA) Sees Strong Trading Volume After Analyst Upgrade
Sana Biotechnology (NASDAQ:SANA) Sees Large Volume Increase on Analyst Upgrade
Sana Biotechnology, Inc. stock logo
HC Wainwright Issues Positive Forecast for Sana Biotechnology (NASDAQ:SANA) Stock Price
HC Wainwright upped their price objective on shares of Sana Biotechnology from $8.00 to $11.00 and gave the company a "buy" rating in a report on Wednesday.
Sana Biotechnology, Inc. stock logo
Sana Biotechnology (NASDAQ:SANA) Stock Rating Upgraded by TD Cowen
TD Cowen raised Sana Biotechnology from a "hold" rating to a "buy" rating in a report on Wednesday.
Sana Biotechnology price target lowered to $7 from $8 at BofA
Sana Biotechnology (SANA) Receives a Buy from Morgan Stanley
Sana Biotechnology, Inc. stock logo
Fmr LLC Has $131.49 Million Stock Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA)
Fmr LLC increased its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 16.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,609,175 shares of the company's stock after purchasing a
Sana Biotechnology announces Fast Track designation for SC291
Sana Biotechnology, Inc. stock logo
Sana Biotechnology (NASDAQ:SANA) Trading 9.8% Higher - Should You Buy?
Sana Biotechnology (NASDAQ:SANA) Stock Price Up 9.8% - Should You Buy?
Sana Biotechnology, Inc. stock logo
Sana Biotechnology (NASDAQ:SANA) Receives Buy Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $8.00 price target on shares of Sana Biotechnology in a research report on Wednesday.
Get Sana Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter.

SANA Media Mentions By Week

SANA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SANA
News Sentiment

0.28

0.44

Average
Medical
News Sentiment

SANA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SANA Articles
This Week

6

3

SANA Articles
Average Week

Get Sana Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SANA) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners